258 filings
Page 3 of 13
SC 13G
TSHA
Taysha Gene Therapies Inc
25 Aug 23
Taysha Gene Therapies / RA CAPITAL MANAGEMENT ownership change
5:01pm
4
TSHA
Taysha Gene Therapies Inc
25 Aug 23
Taysha Gene Therapies / Kamran Alam ownership change
4:30pm
D
TSHA
Taysha Gene Therapies Inc
25 Aug 23
$150.00 mm in equity / options, sold $149.95 mm, 42 investors
4:29pm
SC 13G
TCG Crossover GP I, LLC
25 Aug 23
Taysha Gene Therapies / TCG Crossover GP I ownership change
4:22pm
144
Kamran Alam
24 Aug 23
Notice of proposed sale of securities
5:33pm
8-K
TSHA
Taysha Gene Therapies Inc
24 Aug 23
Taysha Gene Therapies Announces Fast Track Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
8:09am
SC 13D/A
TSHA
Taysha Gene Therapies Inc
21 Aug 23
Taysha Gene Therapies / Manning Paul B ownership change
4:01pm
SC 13D/A
TSHA
Taysha Gene Therapies Inc
18 Aug 23
Taysha Gene Therapies / Astellas Pharma ownership change
5:16pm
4
TSHA
Taysha Gene Therapies Inc
16 Aug 23
Taysha Gene Therapies / Paul B Manning ownership change
8:57pm
4
TSHA
Taysha Gene Therapies Inc
16 Aug 23
Taysha Gene Therapies / John A Stalfort III ownership change
8:53pm
4
TSHA
Taysha Gene Therapies Inc
16 Aug 23
Taysha Gene Therapies / Sean P. Nolan ownership change
8:52pm
4
Donenberg Phillip B.
16 Aug 23
Taysha Gene Therapies / Phillip B. Donenberg ownership change
8:51pm
10-Q
2023 Q2
TSHA
Taysha Gene Therapies Inc
Quarterly report
14 Aug 23
8:36am
8-K
TSHA
Taysha Gene Therapies Inc
14 Aug 23
Entry into a Material Definitive Agreement
7:29am
8-K
TSHA
Taysha Gene Therapies Inc
4 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
8-K
TSHA
Taysha Gene Therapies Inc
31 Jul 23
Taysha Gene Therapies Announces Positive Recommendation from Independent Data Monitoring Committee of REVEAL Phase 1/2 Trial in Rett Syndrome
8:05am
4
TSHA
Taysha Gene Therapies Inc
14 Jul 23
Taysha Gene Therapies / R.A. Session II ownership change
4:00pm
8-K
TSHA
Taysha Gene Therapies Inc
28 Jun 23
Taysha Gene Therapies Provides Clinical Updates for Investigational Programs TSHA-120 in Giant Axonal Neuropathy (GAN) and TSHA-102 in Rett Syndrome at R&D Day
8:31am
4
TSHA
Taysha Gene Therapies Inc
26 Jun 23
Taysha Gene Therapies / Laura Sepp-Lorenzino ownership change
4:50pm
4
TSHA
Taysha Gene Therapies Inc
26 Jun 23
Taysha Gene Therapies / Kathleen Reape ownership change
4:50pm